StockData
LFTD Partners Inc. logo

LFTD Partners Inc. (LIFD) stock

LIFDOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.48MP/E –Yield –

LFTD Partners Inc. reported revenue of $36.96M for the twelve months to Mar 31, 2026. Free cash flow was $1.26M. At the latest close the market valued the company at $1.48M.

Revenue
$36.96M
TTM Q1 2026
Operating income
-$3.32M
TTM Q1 2026
Free cash flow
$1.26M
TTM Q1 2026
EPS, diluted
-$1.99
TTM Q1 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Mar 31, 2026

Valuation

Market cap
$1.48M
P/E ratio
–
Price to sales
0.04
Price to book
0.18
Dividend yield
–
Free cash flow yield
85.30%

Fundamentals

Revenue
$36.96M
Net income
-$28.72M
EPS, diluted
-$1.99
Free cash flow
$1.26M
Book value per share
$0.57
Diluted shares
15M

Trading

Previous close
$0.10
Open
$0.10
Day's range
$0.10 – $0.10
Volume
0
Average volume (20 days)
1,566

Market cap history

Month-end market cap since 2012, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodLIFDS&P 500DifferenceLIFD per yearS&P 500 per year
1 month0.0%+0.6%−0.6 pts
3 months-47.4%+3.4%−50.7 pts
Year to date-47.4%+13.3%−60.6 pts
1 year-63.0%+16.6%−79.6 pts
3 years-96.4%+86.4%−182.8 pts-67.1%+23.1%
5 years-98.2%+81.9%−180.0 pts-55.1%+12.7%
10 years-93.3%+318.9%−412.2 pts-23.7%+15.4%

Fifteen years at a glance

Fiscal years 2011 to 2025 and trailing twelve months, USD

Revenue

$36.96M

Gross profit

$8.70M

Operating income

-$3.32M

Net income

-$28.72M

EPS, diluted

-$1.99

Free cash flow

$1.26M
Reported periodTrailing twelve months

Press releases

Releases LFTD Partners filed with the SEC as exhibits to Form 8-K or 6-K

About LFTD Partners

Pharmaceutical Preparations

LFTD Partners Inc. operates as a holding company that manufactures and markets psychoactive and wellness products primarily through its wholly owned subsidiary, Lifted Made. The company produces hemp-derived psychoactive items, including vapes, edibles, cartridges, and beverages, under brands such as Urb Finest Flowers and Highlandia. It also formulates hemp-free energy and wellness gummies under the Rebel Energy Gummy and Mielos brands, sells kratom-derived products, and provides private-label manufacturing and brand licensing. Lifted distributes finished goods across the United States to smoke and vape shops, convenience stores, and health outlets through wholesale distributors, retail partners, and direct-to-consumer online sales.

Company profile, executives and history

LFTD Partners stock: common questions

What is LFTD Partners's stock price?

LIFD closed at $0.10 on Oct 19, 2026, up 0.00% on the day.

What is LFTD Partners's market cap?

LFTD Partners was worth $1.48M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.

What is LIFD's P/E ratio?

LFTD Partners lost money over the twelve months to Mar 31, 2026 (diluted EPS -$1.99), so it has no meaningful P/E ratio.

How much revenue does LFTD Partners make?

LFTD Partners reported revenue of $36.96M for the twelve months to Mar 31, 2026.

Does LFTD Partners pay a dividend?

No. LFTD Partners has not paid a cash dividend over the last twelve months.

How has LIFD stock performed over the past year?

Including dividends, LIFD returned -63.0% over the past year, against +16.6% for the S&P 500.

Who are LFTD Partners's competitors?

Companies most similar to LFTD Partners by business, industry and size include CVSI, ETST, INBP, BHST, ZOMDF.

See a number that looks wrong?